Cervical cancer mortality in young women in Europe: patterns and trends
Section snippets
Material and methods
Official death certification numbers for 24 European countries (including the Russian Federation, but excluding a few small countries such as Andorra and Liechtenstein) were derived from the World Health Organisation (WHO) database as available on electronic support [8]. During the calendar period considered (1960–1998), five different revisions of the International Classification of Diseases (ICD) were used 9, 10, 11, 12, 13. Classification of cancer deaths were thus re-coded, for all calendar
Results
Table 1 gives the average annual number of certified deaths from cervix, corpus uteri and unspecified uterus for selected European countries around 1960 and 1995. In 1960, the proportion of unspecified uterine cancers ranged between 6.0 in England and Wales, 10.6–12.5% in Switzerland and Norway, and 18.2–26.4% in the other Scandinavian countries to over 70% in France, Greece, Italy and Spain, with several countries showing proportions of unspecified uterine cancers of 35–50%. These figures
Discussion
Two main messages can be derived from the present systematic analysis of uterine cancer mortality in Europe: first, overall national death certification rates can not be used to obtain meaningful measures of patterns of trends in uterine cancer mortality, due to a substantial and variable proportion of deaths from unspecified uterine neoplasms and, second, death certification rates from uterine cancer in younger women (20–44 years) declined substantially in most Western European countries, but
Acknowledgements
Supported by the Swiss League against Cancer and the Italian Association for Cancer Research. The project received financial support from the European Commission (Contract grant sponsor: European Union, Commission of the European Communities, Directorate-General for Employment, Industrial Relations and Social Affairs; Contract grant number: SOC 97 201143).
Neither the European Commission nor any person acting on its behalf is liable for any use made of this information.
References (30)
- et al.
Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994
Eur. J. Cancer
(1999) - et al.
Trends in cancer mortality in young adults in Europe, 1955–1989
Eur. J. Cancer
(1994) Screening for cancerfuture potential
Eur. J. Cancer
(1999)Challenges and pitfalls of mass-screening in the European Union
Eur. J. Cancer
(2000)- et al.
Cancer mortality in Europeeffects of age, cohort of birth and period of death
Eur. J. Cancer
(1998) - et al.
Trends in cancer of the cervix uteri in Sweden following cytological screening
Br. J. Cancer
(1999) - et al.
Incidence of invasive cervical cancer in the Swiss canton of Vaud, and a note on screening
J. Epidemiol. Comm. Health
(1989) - et al.
The continuing increase in adenocarcinoma of the uterine cervixa birth cohort phenomenon
Int. J. Epidemiol.
(1996) - et al.
International trends in the incidence of cervical cancerI Adenocarcinoma and adenosquamous cell carcinoma
Int. J. Cancer
(1998) - et al.
International trends in incidence of cervical cancerII Squamous-cell carcinoma
Int. J. Cancer
(2000)
Cancer incidence and mortality in Europe, 1988–92
J. Epidemiol. Biostat.
Trends in cervix cancer mortality
Cancer Surv.
International Classification of Diseases6th Revision
International Classification of Diseases7th Revision
International Classification of Diseases8th Revision
Cited by (125)
European cancer mortality predictions for the year 2024 with focus on colorectal cancer
2024, Annals of OncologyThe current status of National Cancer Control Plans in Africa: Data from 32 countries
2023, Journal of Cancer PolicyPersisting cancer mortality gap between western and eastern Europe
2022, European Journal of CancerCervical cancer mortality in young adult European women
2020, European Journal of CancerCitation Excerpt :To avoid classification bias, authors decided to present mortality rates from CC, cancer of corpus uteri and unspecified uterine cancer as a single group, only among women under 45. The reason was that the majority of death causes due to uterine cancers, among women in this age group, is caused by CC [8,9]. Mentioned differences in the classification of reproductive organ tumours between individual countries are still present.
To accelerate cancer prevention in Europe: Challenges for cancer registries
2018, European Journal of Cancer